AusperBio Doses First Patient in Clinical Trial of...
Category : Clinical Trial Update 5 August 2026AusperBio Advances Its Second Clinical-Stage Hepatitis B Therapy AusperBio Therapeutics Inc. and...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Otsuka Shares New Phase 3 Data Showing Voyxact Slo...
Category : Clinical Trial Update 5 August 2026New Two-Year Phase 3 Results Highlight Long-Term Benefits of Voyxact Otsuka Pharmaceutical Develo...
EyePoint Completes Enrollment in Phase 3 Duravyu T...
Category : Clinical Trial Update 4 August 2026EyePoint Reaches Major Clinical Development Milestone EyePoint, Inc. has announced that it has co...
Acurx Receives Positive FDA Guidance for Ibezapols...
Category : Clinical Trial Update 4 August 2026FDA Supports Continued Development of Ibezapolstat Acurx Pharmaceuticals has announced a positive...
Triquetra Health Launches BioActive Vitamin B1 Cli...
Category : Approval/Launch 4 August 2026New Supplement Combines High-Dose Benfotiamine with Essential Cofactors Triquetra Health has anno...
Latest Newsletter Post
-
Otsuka Shares New Phase 3 Data Show..
5 August 2026
-
AusperBio Doses First Patient in Cl..
5 August 2026
-
Triquetra Health Launches BioActive..
4 August 2026
-
Acurx Receives Positive FDA Guidanc..
4 August 2026
-
EyePoint Completes Enrollment in Ph..
4 August 2026
